Evidence map›Paper›PMID 19184647›Full record

ReviewHandbook of experimental pharmacology2009

The road to discovery of neuronal nicotinic cholinergic receptor subtypes.

Allan C Collins, Outi Salminen, Michael J Marks, Paul Whiteaker, Sharon R Grady

Abstract readReview
In one paragraph

Review in Handbook of experimental pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Genetics and smoking.Current addiction reports · 2014
    Article
  6. Nicotinic receptor antagonists as treatments for nicotine abuse.Advances in pharmacology (San Diego, Calif.) · 2014
    Review
  7. Article
  8. Article
  9. Article
  10. Chromosome 20 shows linkage with DSM-IV nicotine dependence in Finnish adult smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2012
    Article
  11. Article
  12. Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  13. Associations of nicotine intake measures with CHRN genes in Finnish smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2011
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Allan C CollinsInstitute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA. al.collins@colorado.edu
Outi Salminen
Michael J Marks
Paul Whiteaker
Sharon R Grady

Funding

Project 3 University of Colorado, BoulderU19DA019375 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MARKS, MICHAEL J · 2005 to 2014
$8.3M
GENETICS OF NICOTINE TOLERANCE: ROLE OF RECEPTORSR01DA003194 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 1985 to 2013
$5.5M
Studies with Nicotinic Null Mutant MiceP30DA015663 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 2003 to 2013
$4.5M
ALPHA-CONOTOXIN MII--SELECTIVE NICOTINIC RECEPTOR PROBER01DA012242 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WHITEAKER, PAUL · 1999 to 2011
$3.5M
NIDA NIH HHS P30 DA015663NIDA NIH HHS P30DA-015663NIDA NIH HHS R01 DA003194NIDA NIH HHS R01DA-003194NIDA NIH HHS R01 DA012242NIDA NIH HHS R01DA-012242NIDA NIH HHS U19 DA019375NIDA NIH HHS U19DA-019375
6 · The paper itself

Abstract

The discovery that mammalian brain expresses the mRNAs for nine different nicotinic cholinergic receptor subunits (alpha2-alpha7, beta2-beta4) that form functional receptors when expressed in Xenopus laevis oocytes suggests that many different types of nicotinic cholinergic receptors (nAChRs) might be expressed in the mammalian brain., Using an historical approach, this chapter reviews some of the progress made in identifying the nAChR subtypes that seem to play a vital role in modulating dopaminergic function. nAChR subtypes that are expressed in dopamine neurons, as well as neurons that interact with dopamine neurons (glutamatergic, GABAergic), serve as the focus of this review. Subjects that are highlighted include the discovery of a low affinity alpha4beta2* nAChR, the identity of recently characterized alpha6* nAChRs, and the finding that these alpha6* receptors have the highest affinity for receptor activation of any of the native receptors that have been characterized to date. Topics that have been ignored in other recent reviews of this area, such as the discovery and potential importance of alternative transcripts, are presented along with a discussion of their potential importance.

Indexed as

Gene ExpressionAnimalsBrainDopamineHumansNeuronsProtein SubunitsReceptors, NicotinicRNA, MessengerDopamineProtein SubunitsReceptors, NicotinicRNA, Messenger

Identifiers

PMID19184647
PMCPMC8759235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.